The Symbiotic Effect and Evolutionary Game Analysis of Quantity Procurement System and Innovation Development of Pharmaceutical Enterprises under Government Regulation
DOI:
https://doi.org/10.54097/fbem.v11i2.12576Keywords:
Purchase with quantity, Symbiotic effect, Evolutionary game, Innovative development, Simulation analysis.Abstract
The government and pharmaceutical enterprises are the two important subjects in the implementation of the system. On the one hand, the government's implementation of the policy promotes the innovative development of pharmaceutical enterprises, on the other hand, it also realizes the deepening development of the system from the upgrading of drug quality caused by the innovative development of pharmaceutical enterprises, which is conducive to the positive symbiotic effect of the two. Based on the two main bodies of government and pharmaceutical enterprises, this paper reveals the interaction mechanism between the procurement system with quantity and the innovation of pharmaceutical enterprises. Based on the evolutionary game theory, this paper discusses the dynamic selection process between the procurement system with quantity and the innovation and development of pharmaceutical enterprises. Matlab simulation is used to analyze the profit and loss parameter conditions under different stable strategies. The results show that the government should give full play to its macro-control ability in the implementation of the procurement policy with quantity, reasonably control the innovation subsidies to pharmaceutical enterprises so as to maximize the innovation intention of pharmaceutical enterprises and to guide the standardized development of the original drug, generic drug and innovative drug market, accelerate the formation of a reasonable drug price mechanism, and promote the high-quality development of the pharmaceutical industry. Finally, based on the research conclusions, this paper provides reference opinions for the development and improvement of the national drug centralized procurement system, and also provides an important basis for pharmaceutical enterprises to make innovative choices and transformation and upgrading under the background of national centralized procurement.
Downloads
References
Yao Bingyang, Chen Qingjiang. Analysis of the current situation, problems and countermeasures of China's medical reform in the new era[J]. Medical contention, 2020,11 (05): 52-55+58. DOI: 10.3276/j.issn.1674-8913.2020.05.013.
Zhang Xinxin, Hou Wenhua, Shen Chenglin. Research on Innovation Incentive and Market Performance of Pharmaceutical Enterprises under Centralized Procurement Regulation [J]. Systems Engineering Theory and Practice, 2017,37(06):1557-1567.
SHAO Rong, XIE Jin Ping, JIANG Rong. Analysis of purchasing organization of American group and its inspiration to China's drug purchasing [J]. China Health Policy Research, 2014,7(06):35-40.
Guo Chunli. Pharmaceutical Production and Circulation in China: System Status, Existing Problems and Policy Orientation [J]. Economist, 2013, No.177 (09): 24-33. DOI: 10.16158/J. Cnki.51-1312/F.2013.09.001.
Liu Quanhong, Liu Fang. The development of pharmaceutical industry in China and the status quo, problems and policy suggestions of industrial policy [J]. Economic Research Reference, 2,014, No.2592 (32): 39-67. DOI: 10.16110/J. Cnki. ISSN 2095-3151.2014.32.010.
He Rui, Ge Jing, He Mengjiao, Lu Yun. Analysis of the Factors Influencing the Price Reduction of Drug Delivery from the Perspective of Game Theory [J]. China Pharmacy, 2020,31(09):1025-1029.
Li Yiren, Lu Yun, Feng Chang. Research on the rules of drug volume procurement based on the bidding game of enterprises [J]. Price Theory and Practice, 20 20, No.427 (01): 74-77+177. DOI: 10.19851/J.Cnki.Cn11-1010/F.2020.01.075.
Tan Qingli, Wang Haoyang. Game Analysis on the Problem of Over-supply between the National Organization of Centralized Drug Purchase and Use of the Joint Procurement Office and the Winning Enterprise in Drug Volume Procurement [J]. Medicine and Society, 2021, 34 (08): 129-134. DOI: 10.13723/J. YXYS H.2021.08.026.
Liu Wei, chenchen. The Impact of Mergers and Acquisitions on Innovation Performance of Pharmaceutical Manufacturing Industry: An Empirical Analysis Based on CDM Model [J]. review of industrial economics (Shandong University), 2020,19(03):1-22.
LU Zhi, LI Guang Qin. Tax Administration and Enterprise Innovation: Empirical Evidence from the World Bank's Enterprise Survey in China [J]. Beijing Social Sciences, 2022, No.231 (07): 97-107. DOI: 10.13262/J. BJSHKXY. BJSHKX.220710.
Wang wenbing, Wang yuhui, gan shengdao. analysis of cost composition of successful pharmaceutical companies under the background of pharmaceutical volume procurement [J]. price theory and practice, 2019, no 415 (01): 56-59. doi: 10.19851/j cnki.cn11-1010/f.2019.01.014.
Tan Qingli, Miogo Chen. Analysis of the Dynamic Impact of the Promotion of Drug Delivery Procurement Policy on Chinese Pharmaceutical Enterprises [J]. chinese health economics, 2020,39(08):13-17.
Chen Zhihong, Hong Xu. Interpretation and empirical analysis of centralized drug procurement policy in China [J]. Journal of Systems Management, 2021,30(01): 170-179.
Luo Zhibo, Zhu Guilong, Liu Juyan, Yang Jun, Bao Yingxia, Wang Jiansong. Restructuring and innovation of pharmaceutical industry chain under volume procurement [J]. chinese journal of pharmaceuticals, 2022, 53 (08): 1209-1216. DOI: 10.16522/J.CN Ki.CJPH.2022.08.018.
Zhang Qin-fang. Study on the influence of quantity procurement on the performance of pharmaceutical enterprises from the perspective of dynamic capability [D]. Donghua University, 2023. DOI: 10.27012/D.CNKI.gdhuu.2022.001196.
Zhang Qiuyu, Lu Xiaolong, Wang Yun, Hu Yuanxia, Fang Shilin, Xu Lulu. The Impact of Drug Centralized Volume Purchase Policy on Innovation Performance of Listed Companies in China's Pharmaceutical Manufacturing Industry [J]. Medicine and Society, 2022, 35 (12): 17-23. DOI: 10.13723/J. YXYSH.022.12.004.
Xue Y . Game Models of Construction Project Bidding with a Composite Base Price[C]// 20 14 International Conference on Construction and Real Estate Management. 2014.
Fan W, Wang S, Gu X, et al. Evolutionary game analysis on industrial pollution control of lo cal government in China[J]. Journal of Environmental Management, 2021, 298: 113499.
Zhu Lilong, Rong Meimei, Zhang Siyi. Evolutionary Game and Simulation Analysis of Drug Safety and Quality Supervision under the Government's Reward and Punishment Mechanism [J]. China Management Science, 2021, 29 (11): 55-67. DOI: 10.16381/J. Cnki. ISSN 1003-207X.2019.0481.
Donelan R, Walker S, Salek S. Factors influencing quality decision‐making: regulatory and p harmaceutical industry perspectives[J]. Pharmacoepidemiology and drug safety, 2015, 24(3): 319- 328.
Li Dongsheng, Bai Xueshan. The general mechanism of volume purchase to reduce drug prices and the analysis of "4+7 recruitment model" [J]. Health Economics Research, 2019, 36 (08): 10-12. DOI: 10.14055/J.CN KI.33-1056/F.2019.08.003.
Yan Juanjuan, Zhao Yaowei, Yan Bin, et al. Research on the Implementation Effect of Drug Volume Purchase Policy Based on Discontinuous Time Series [J]. Price Theory and Practice, 2022, No.462 (12): 56-60+195. DOI: 10.19851/J.Cnki.Cn11-1010/F.2022.12.383.
Wang Xiangyin, Yin Wenjiang, Fan Chengxin, et al. An economic analysis of the welfare effect of the policy of purchasing drugs with volume [J]. chinese health service management, 2022,39(07):518-519+544.
Yu qiaoping. research on the evaluation of the implementation effect of drug quantity procurement in public hospitals in China-taking Anqing public hospital in Anhui province as an example [J]. price theory and practice, 2021, no 446 (08): 65-68. doi: 10.19851/j cnki.cn11-1010/f 2021.08.254.
Tan Zaixiang ,Fan Shun .Talking about the challenges and countermeasures of pharmaceutical enterprises under the background of "4+7" volume centralized procurement of pharmaceutical products [J]. Health Economic Research, 2019,36 (08): 13-15+19. DOI: 10.14055/J.CN KI.33-1056/F.2019.08.004.
Tan Zaixiang, Song Qingqing. Research on legal risks and countermeasures of drug supply in public hospitals under the background of expansion of drug 4+7 volume procurement [J]. chinese health service management, 2020,37(12):913-915+931.
Yang Xinyue, Li Yibing, Hai Sang. Research on the Competitiveness and Market Efficiency of China's Pharmaceutical Industry: An Analysis of the Impact of Volume Purchasing on Pharmaceutical Prices [J]. Price Theory and Practice, 2019, No.415 (01): 51-55. DOI: 10.19851/J. Cnki. Cn11-1010/f.2019.01.013.
Song Yan, Zhen Tianmin. Evolutionary Game and Countermeasure Analysis of Drug Safety Supervision [J]. China Pharmacy, 2016,27(19):2593-2 595.
Jin Hao, Liu Demin, An Ming. Evolutionary game analysis of drug quality supervision under the scenario of factor input efficiency [J]. Journal of Systems Engineering, 2022, 37 (03): 303-316. DOI: 10.13383/J.Cnki.JSE.2022.03.002.
